MRNA vaccine technology faces growing doubts among state and federal lawmakers. The opposition comes at a critical juncture ...

A new study from Memorial Sloan Kettering Cancer Center has shown that an RNA-based neoantigen vaccine can generate ...

Christopher Ridley, a spokesperson for Moderna, said the state legislative efforts are largely a product of ...

HHS is re-evaluating a nearly $600 million contract with Moderna to develop and test vaccines against flu viruses that could ...

COVID-19 vaccines made by Pfizer and Moderna are both mRNA vaccines, which teach the body to recognize and fight off the ...

An Indian origin scientist Vinod Balachandran, MD, in latest data from the phase 1 trial has revealed that an investigational ...

Five years after the start of the pandemic, the fight over who owns the underlying technologies that made the Covid-19 ...

To maintain vaccine efficacy, WHO regularly updates influenza vaccine strains based on global epidemiological, virological, ...

Developing messenger RNA vaccines such as the Pfizer-BioNTech and Moderna candidates has been fast because scientists were able to start their work before there was a known case of the novel ...

Five years ago, on March 11, the World Health Organization declared COVID-19 a global pandemic. The vaccines “underwent the most intensive safety analysis in U.S. history." ...

As viral vaccines are increasingly used to meet global health needs, the pharmaceutical industry is manufacturing larger ...

"We expect 2025 to be a data-rich year with multiple important updates from our priority programs," said Chief Executive Ugur Sahin. BioNTech forecast revenue between 1.7 billion euros and 2.2 billion ...